Este sitio web utiliza Cookies propias para recopilar información con la finalidad de mejorar nuestros servicios, así como el análisis de sus hábitos de navegación. Si continúa navegando, supone la aceptación de la instalación de las mismas. El usuario tiene la posibilidad de configurar su navegador pudiendo, si así lo desea, impedir que sean instaladas en su disco duro, aunque deberá tener en cuenta que dicha acción podrá ocasionar dificultades de navegación de página web.

Acepto
Cómo configurar

CIDETEC organized a roundtable on translational research in nanomedicine in BioSpain 2016.

17/10/2016
The event took place on September 28 and revolved around the development of nanomedicine and the main challenges posed by the transfer of these innovative technologies all the way from the laboratory to the early clinical phases, related mainly to characterization processes, the transfer of technology, regulatory requirements, industry and the market.

The roundtable was conducted by Dr. Ana Benito, a researcher of the Unit Biomaterials at CIDETEC together with Covadonga Pañeda (Director of R & D Sylentis), Simon Bacconier (Transnational Access coordinator at the EU Lab for characterization in nanomedicine), Iraida Loinaz (Health BDM at CIDETEC), Eusebio Gainza (Director of R & D BioPraxis Research) and Justin Barry (MD at Midatech Pharma).

BioSpain is the largest event in the biotechnology sector in Spain and is organized by ASEBIO, the Spanish association of the biotechnology industry. The eighth edition was held from 28 to 30 September at the Bilbao Exhibition Centre (BEC) and brought together about 30 countries, including the United States as a guest.

The opening ceremony was attended by the Minister of Economic Development and Competitiveness, Arantxa Tapia, as well as the president of Asebio, Jordi Martí; the commercial attache of the US Embassy in Spain, Keith Silver; the CEO of the Institute of Foreign Trade, Francisco Javier Garzón; and the Secretary General of Health, José Javier Castrodeza.

Share